Cargando…

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma is the second most deadly cancer with late presentation and limited treatment options, highlighting an urgent need to better understand HCC to facilitate the identification of early-stage biomarkers and uncover therapeutic targets for the development of novel the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yu, Lee, Wai Yeow, Toh, Soo Ting, Tennakoon, Chandana, Toh, Han Chong, Chow, Pierce Kah-Hoe, Chung, Alexander Y.-F., Chong, Samuel S., Ooi, London L.-P.-J., Sung, Wing-Kin, Lee, Caroline G.-L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701074/ https://www.ncbi.nlm.nih.gov/pubmed/31429776 http://dx.doi.org/10.1186/s12967-019-2025-x

Ejemplares similares

Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2014)

Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2016)

MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival
por: Wang, Yu, et al.
Publicado: (2013)

BATVI: Fast, sensitive and accurate detection of virus integrations
por: Tennakoon, Chandana, et al.
Publicado: (2017)

The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma
por: Ang, Soo Fan, et al.
Publicado: (2015)

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

Correction: The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma
por: Ang, Soo Fan, et al.
Publicado: (2015)

Retroperitoneal liposarcomas: the experience of a tertiary Asian center
por: Lee, Ser Yee, et al.
Publicado: (2011)

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
por: Huynh, Hung, et al.
Publicado: (2009)

Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma
por: Han, Jian, et al.
Publicado: (2021)

BatAlign: an incremental method for accurate alignment of sequencing reads
por: Lim, Jing-Quan, et al.
Publicado: (2015)

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
por: Garnelo, Marta, et al.
Publicado: (2017)

Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression
por: Chong, Yong Chun, et al.
Publicado: (2020)

A Case of Well-differentiated Hepatocellular Carcinoma Identified on Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Huang, Hian Liang, et al.
Publicado: (2018)

Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2020)

Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2021)

ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing
por: Li, Guoliang, et al.
Publicado: (2010)

Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC‐driven hepatocellular carcinoma
por: Thng, Dexter Kai Hao, et al.
Publicado: (2022)

Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
por: Huynh, Hung, et al.
Publicado: (2019)

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis
por: Huynh, Hung, et al.
Publicado: (2003)

Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma
por: Chin, Ken Min, et al.
Publicado: (2018)

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
por: Chew, Valerie, et al.
Publicado: (2011)

Epigenetics of hepatocellular carcinoma
por: Toh, Tan Boon, et al.
Publicado: (2019)

Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate
por: Lee, Sang-Yun, et al.
Publicado: (2021)

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
por: Zhao, Yue, et al.
Publicado: (2018)

BatMeth: improved mapper for bisulfite sequencing reads on DNA methylation
por: Lim, Jing-Quan, et al.
Publicado: (2012)

Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma
por: Grinchuk, Oleg V., et al.
Publicado: (2017)

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study
por: Gandhi, Mihir, et al.
Publicado: (2021)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis
por: Chong, Yuk Kien, et al.
Publicado: (2015)

BioCarian: search engine for exploratory searches in heterogeneous biological databases
por: Zaki, Nazar, et al.
Publicado: (2017)

Challenges in the classification and management of Asian youth-onset diabetes mellitus- lessons learned from a single centre study
por: Yeow, Toh Peng, et al.
Publicado: (2019)

Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
por: Lim, Jhin Jieh, et al.
Publicado: (2022)

Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
por: Lim, Jhin Jieh, et al.
Publicado: (2022)

Tailoring precision immunotherapy: coming to a clinic soon?
por: Han, Shuting, et al.
Publicado: (2020)

Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
por: Wang, Who-Whong, et al.
Publicado: (2013)

Awakening immunity against cancer: a 2017 primer for clinicians
por: Jain, Amit, et al.
Publicado: (2017)

Atezolizumab plus Bevacizumab versus Sorafenib for Unresectable Hepatocellular Carcinoma: Results from Older Adults Enrolled in the IMbrave150 Randomized Clinical Trial
por: Li, Daneng, et al.
Publicado: (2022)

The Prevalence of Advanced Liver Fibrosis Among Patients With Type 2 Diabetes Mellitus: A Single-Centre Experience in Penang, Malaysia
por: Lee, Xe Hui, et al.
Publicado: (2023)

Chorea in Sporadic Creutzfeldt-Jakob Disease
por: Tan, Ai Huey, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j2jk738lj9nm62a4gkkpsh04vg